STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in two major investor conferences in December 2024. The company will present at the Evercore ISI HealthCONx Conference on December 4 at 9:10 a.m. ET and the Citi Global Healthcare Conference on December 5 at 1:00 p.m. ET. Both fireside chat sessions will be available via webcast on the company's website under the 'Events and Presentations' page, with replays accessible for approximately 90 days after the events.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

WALTHAM, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following December investor conferences:

  • Evercore ISI HealthCONx Conference: Fireside chat on Wednesday, December 4, 2024, at 9:10 a.m. ET
  • Citi Global Healthcare Conference: Fireside chat on Thursday, December 5, 2024, at 1:00 p.m. ET

The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Meredith Kaya 
meredith.kaya@apellis.com
617.599.8178


FAQ

When is Apellis Pharmaceuticals (APLS) presenting at the Evercore ISI HealthCONx Conference in December 2024?

Apellis Pharmaceuticals will present at the Evercore ISI HealthCONx Conference on Wednesday, December 4, 2024, at 9:10 a.m. ET.

What time is Apellis Pharmaceuticals (APLS) presenting at the Citi Global Healthcare Conference in December 2024?

Apellis Pharmaceuticals will present at the Citi Global Healthcare Conference on Thursday, December 5, 2024, at 1:00 p.m. ET.

How long will the webcasts of Apellis Pharmaceuticals (APLS) December 2024 investor conferences be available?

The webcasts will be available for approximately 90 days following each event on the company's website.

Where can I watch Apellis Pharmaceuticals (APLS) December 2024 investor conference presentations?

The webcasts will be available on the 'Events and Presentations' page of the 'Investors and Media' section on Apellis Pharmaceuticals' website.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.73B
106.61M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM